13F-HR filed by SECTOR GAMMA AS
SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-11, with 30 holding rows worth $290,875,383.
- Accession
- 0000945621-25-000153
- Filer
- CIK 1475373
- Filed
- 2025-02-11
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 30 entries on the cover page, a total value of $290,875,383 stated on the cover page (in dollars after the unit check, H1), rows summing to $290,875,383 with VALUE read as dollars as filed, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Pfizer Inc. | 717081103 | COM | 1,155,000 | $30,642,150 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 320,000 | $25,561,600 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 366,166 | $20,710,349 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 197,500 | $18,243,075 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 76,000 | $17,242,120 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 137,714 | $14,546,730 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 217,348 | $14,286,284 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 197,400 | $13,634,418 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 46,000 | $11,989,440 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 78,000 | $11,280,360 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 88,000 | $10,407,760 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 170,000 | $10,298,600 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 217,000 | $9,741,130 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 158,970 | $9,318,821 | dollars as filed | |
| QIAGEN NV | N72482149 | COMMON STOCK-FO | 203,993 | $9,083,808 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 235,842 | $8,245,036 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 99,000 | $7,328,970 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 17,279 | $6,374,223 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 16,829 | $5,528,495 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 158,650 | $4,626,234 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 40,000 | $4,558,000 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 29,000 | $4,434,680 | dollars as filed | |
| GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 36266G107 | Stock | 50,000 | $3,909,000 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 14,000 | $3,551,940 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 276,907 | $3,353,344 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 65,250 | $2,945,385 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 22,000 | $2,777,060 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372AB0 | NOTE 1.500% 5/0 | 66,023 | $2,378,148 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 25,712 | $2,300,196 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 48,495 | $1,578,027 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000945621-25-000153 | this filing | 2025-02-11 | acceptance time not in the bulk data set |